Impact assessment

COVID-19 autumn 2023 vaccination programme: cost effectiveness impact assessment

Impact assessment into the cost effectiveness of the COVID-19 autumn 2023 vaccination programme.

This was published under the 2022 to 2024 Sunak Conservative government

Documents

COVID-19 autumn 2023 vaccination programme: cost effectiveness impact assessment

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Department of Health and Social Care presented cost-effectiveness analysis to the Joint Committee on Vaccination and Immunisation (JCVI). This analysis was one of the factors informing JCVI’s advice for the COVID-19 vaccination programme for autumn 2023.

This impact assessment details this analysis and appraises the cost-effectiveness of several options for the COVID-19 autumn 2023 booster programme that government could take, including the option advised by JCVI. Figures in the analysis have been redacted to protect commercially sensitive information.

Updates to this page

Published 5 October 2023

Sign up for emails or print this page